Showing results (51-60 of 109) with videos related to

Sort By:
Pageof 11
Elife|June 28, 2013
Evolutionary dynamics of cancer in response to targeted combination therapyIvana Bozic, Johannes G Reiter, Benjamin Allen, et al.
Journal for Immunotherapy of Cancer|December 15, 2023
Immune microenvironment of basal cell carcinoma and tumor regression following combined PD-1/LAG-3 blockadeJulie Stein Deutsch, Jonathan Lai, Kara M Schenk, et al.
The Oncologist|April 19, 2019
Sicca Syndrome Associated with Immune Checkpoint Inhibitor TherapyBlake M Warner, Alan N Baer, Evan J Lipson, et al.
Nature Immunology|July 15, 2020
Neuropilin-1 is a T cell memory checkpoint limiting long-term antitumor immunityChang Liu, Ashwin Somasundaram, Sasikanth Manne, et al.
Journal of Translational Medicine|July 6, 2015
Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant settingEvan J Lipson, William H Sharfman, Shuming Chen, et al.
Journal for Immunotherapy of Cancer|September 12, 2025
Analysis of treatment-free survival of patients with advanced melanoma receiving nivolumab as monotherapy or in combination with relatlimab in RELATIVITY-047Meredith M Regan, Paolo A Ascierto, Evan J Lipson, et al.
Journal for Immunotherapy of Cancer|June 25, 2025
SITC vision: Opportunities for deeper understanding of mechanisms of anti-tumor activity, toxicity, and resistance to optimize cancer immunotherapyRyan J Sullivan, Anthony R Cillo, Robert L Ferris, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2019
Pan-Tumor Pathologic Scoring of Response to PD-(L)1 BlockadeJulie E Stein, Evan J Lipson, Tricia R Cottrell, et al.
Journal of Neurosurgery. Spine|May 6, 2023
Safety and clinical efficacy of immune checkpoint inhibition and stereotactic body radiotherapy in patients with spine metastasisEmerson Lee, Xuguang Chen, Michael C LeCompte, et al.
The American Journal of Surgical Pathology|August 18, 2017
Cutaneous Eruptions in Patients Receiving Immune Checkpoint Blockade: Clinicopathologic Analysis of the Nonlichenoid Histologic PatternGenevieve J Kaunitz, Manisha Loss, Hira Rizvi, et al.
Pageof 11